 intermitt inject vs patient-control analgesia sickl cell crisi pain comparison patient emerg depart purpos studi prospect assess morphin sulfat administr intermitt intraven IV inject int-iv patient-control analgesia pca patient emerg depart ED sickl cell crisi pain patient bed rest intraven hydrat linear analog scale pain intens verbal pain scale level alert vital sign minut time discharg ED patient int-iv pca phase patient int-iv group morphin sulfat mg IV minut necessari linear analog scale pain intens mm patient pca group morphin sulfat mg bolu mg lockout phase patient int-iv group morphin sulfat mg IV minut necessari linear analog scale pain intens mm patient pca group morphin sulfat mg bolu mg lockout data unpair test gener linear model mann-whitney test test phase patient year int-iv patient year pca treatment group durat pain amount morphin linear analog scale pain intens verbal pain scale level alert vital sign final respiratori rate int-iv phase patient year int-iv patient year pca pca group elaps time onset pain treatment hour int-iv group hour treatment group respect total amount morphin linear analog scale pain intens verbal pain scale vital sign level alert pca group signific reduct length stay ED phase phase ED discharg rate incid side effect group low- high-dos regimen pca safe effect place int-iv administr morphin ED treatment sickl cell crisi pain